The number of people with susceptibility test result for rifampicin in Saint Vincent and the Grenadines
Saint Vincent and the Grenadines: The number of people with susceptibility test result for rifampicin was 0 in 2021. ◆ Volatile
Latest (2021)
0
Change on year
down 100.0%
World rank
146th
of 155 countries
All-time high
13
in 2020
All-time low
0
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Saint Vincent and the Grenadines, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
In 2021, the number of people with susceptibility test result for rifampicin in Saint Vincent and the Grenadines stood at 0. That is the lowest value across all 5 years on record.
That represents a change of down 100.0% on the previous year.
That places Saint Vincent and the Grenadines 146th out of 155 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in Saint Vincent and the Grenadines, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 0 | — |
| 2018 | 6 | — |
| 2019 | 4 | -33.3% |
| 2020 | 13 | +225.0% |
| 2021 | 0 | -100.0% |
Saint Vincent and the Grenadines compared with similar countries
- Saint Vincent and the Grenadines's 0 is below the median for upper middle income countries, which is 880. (46 countries reporting)
- Saint Vincent and the Grenadines's 0 is below the median for Latin America & Caribbean, which is 406.5. (26 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 3.33 | 0 | 6 | 3 |
| 2020s | 6.5 | 0 | 13 | 2 |
Countries ranked near Saint Vincent and the Grenadines
- 143 Saint Lucia 2 compare
- 143 Bermuda 2 compare
- 143 Andorra 2 compare
- 146 Grenada 0 compare
- 146 Niue 0
- 146 Mauritania 0 compare
- 146 Barbados 0 compare
- 146 Saint Kitts and Nevis 0 compare
- 146 Sao Tome and Principe 0 compare
- 146 Vanuatu 0 compare
- 146 South Sudan 0 compare
- 146 Antigua and Barbuda 0
More health data for Saint Vincent and the Grenadines
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.3888 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,524 deaths per 1,000 people (2090)
- Number of infants who die before age 1 1 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0294 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.07 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Saint Vincent and the Grenadines?
- The number of people with susceptibility test result for rifampicin in Saint Vincent and the Grenadines was 0 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Saint Vincent and the Grenadines?
- The highest recorded value was 13 in 2020.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Saint Vincent and the Grenadines?
- The lowest recorded value was 0 in 2017.
- How does Saint Vincent and the Grenadines rank for the number of people with susceptibility test result for rifampicin?
- Saint Vincent and the Grenadines ranks 146th out of 155 countries with data for 2021.
- Where does this Saint Vincent and the Grenadines data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).